Shockwave has been making waves this summer! As you dive into this edition of the PulsePoint Newsletter, you’ll see that JACC: Cardiovascular Interventions published a trilogy of peer-reviewed publications highlighting Shockwave’s MOA, a pooled analysis of the 4 Disrupt CAD studies, and Disrupt PAD lll. Dive deeper and you’ll discover the incredible 10-webinar series called Calcium Masterclass that was launched at the beginning of the quarter. Explore how Shockwave was granted transitional pass-through reimbursement for Coronary IVL and proposed additional payment for hospital in-patient Coronary IVL cases performed in the United States. This PulsePoint has a lot to cover – recap the rest of the events and milestones from an exciting last quarter. But as you relax on your vacation, always stay on the pulse!
Read More
Topics:
Coronary IVL,
IVL Case,
Peripheral IVL,
IVL Technology,
Coronary Cases,
Peripheral Cases,
Shockwave C2,
Shockwave M5,
Shockwave S4,
PulsePoint Newsletter,
Coronary IVL - U.S.
PulsePoint is back! Bringing you a highlight reel of the most memorable moments, successes and key events of Q1 for both our coronary and peripheral technology. Most notably, Shockwave had a history-making moment in February of this year when we received FDA approval in the U.S. for Coronary IVL! Since then, we have seen many physicians achieving great success utilizing the technology. We also brought a new podcast, ChalkTalk, to life, and so much more we want to share with you. Check out the latest PulsePoint for the full scoop!
Read More
Topics:
Coronary IVL,
IVL Case,
Peripheral IVL,
IVL Technology,
Coronary Cases,
Peripheral Cases,
Shockwave C2,
Shockwave M5,
Shockwave S4,
PulsePoint Newsletter,
Coronary IVL - U.S.
From Data to Daily Practice; Disrupting Calcium with IVL across multiple vessel beds.
Read More
Topics:
Medical Meetings,
Peripheral IVL,
DISRUPT PAD,
Peripheral Conferences,
Peripheral Clinical Data
IVL use in real world CFA population shows low residual stenosis and 0% complications.
Read More
Topics:
Peripheral IVL,
Peripheral Cases
Welcome to ChalkTalk, our new podcast series where we discuss all things cardiovascular calcium, featuring perspective from our leaders and leading physicians who are using IVL in clinical practice to crack their toughest cases. We plan to bring you the latest cases, insights & evidence surrounding both coronary and peripheral Shockwave IVL.
Read More
Topics:
Shockwave Behind-the-Scenes,
Coronary IVL,
Peripheral IVL,
IVL Technology,
ChalkTalk Podcast
Your first Shockwave IVL newsletter, PulsePoint, has arrived. We’re kicking off with an ambitious recap of 2020, celebrating key milestones and major events for our customers using our peripheral technology across the globe. Released on a quarterly basis moving forward, PulsePoint will be the one stop shop for all the latest news and updates throughout the year. We hope you enjoy our first global edition of PulsePoint.
Read More
Topics:
Peripheral IVL,
Peripheral Cases,
PulsePoint Newsletter
The treatment of calcified below-the-knee (BTK) lesions is challenging, associated with sub-optimal procedural outcomes, resulting in early recoil, and may contribute to restenosis.
Read More
Topics:
Peripheral IVL,
DISRUPT PAD,
Peripheral Cases,
PAD Applications - BTK,
PAD Applications - CLI,
Peripheral Clinical Data
Following the excitement of the PAD III RCT results presented at VIVA in November, a rock star faculty of Prof. Gunnar Tepe, Prof. Thomas Zeller, Dr. Arne Schwindt and Dr. Lorenzo Patrone assembled for an incathlab session to discuss the study results and how IVL offers superior vessel preparation over conventional PTA in severely calcified PAD lesions.
Read More
Topics:
Peripheral IVL,
DISRUPT PAD,
Peripheral Clinical Data
At the recent PCR Valves eCourse (aka London Valves), an esteemed faculty reported on the use of IVL- facilitated TAVI. Profs./Drs. Carlo Di Mario, Ole De Backer, Joachim Schofer, Constantin von zur Mühlen used published data and case experiences to illustrate the advantages of using IVL to maintain transfemoral access in TAVI patients with severely calcified iliacs. Considering the importance of reducing complications to minimize hospital stay, the faculty expressed enthusiasm when considering the use of IVL in these very complex patients. Happy viewing!
Read More
Topics:
Peripheral IVL,
DISRUPT PAD,
Peripheral Clinical Data
In life, and when treating patients, we all prefer things to be less complicated. Unfortunately, treating peripheral vascular calcification is typically associated with suboptimal vessel expansion and an increased risk of complications.
Read More
Topics:
Peripheral IVL,
DISRUPT PAD,
Peripheral Clinical Data
